The multitasking PDA-PEG-R848-CD NPs were able destroy 4T1 breast tumors under near-infrared laser irradiation as well as yield tumor-associated antigens, significantly potentiating the systemic efficacy of PD-L1 checkpoint blocking therapy by activating the innate and adaptive immune systems in vivo [151]. The gene discussed is CD274; the disease is neoplasm.